Apigenin vs Magnesium L-Threonate
A side-by-side research comparison of Apigenin and Magnesium L-Threonate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Apigenin | Magnesium L-Threonate |
|---|---|---|
| Full name | Apigenin (Flavone) | Magnesium L-Threonate (Magtein) |
| Category | Sleep & Recovery | Sleep & Recovery |
| Status | OTC supplement | OTC supplement |
| Mechanism | Binds benzodiazepine sites on GABA-A receptors for mild anxiolytic and sedative effects, and inhibits CD38, an NAD-consuming enzyme, thereby helping preserve cellular NAD+ levels. Also provides antioxidant and anti-inflammatory activity. | The L-threonate carrier improves brain magnesium uptake, increasing synaptic density and NMDA receptor regulation. This supports memory, learning, and calmer nervous-system tone, and improves sleep architecture. |
| Molecular weight | 270.24 Da | 294.5 Da (complex) |
| Half-life | ~5-10 hours | Varies (magnesium homeostasis) |
| Bioavailability | Low; enhanced by fat and formulation | High brain penetrance vs other magnesium salts |
| Typical dose | 50 mg per day | ~1.5-2 g compound (~144 mg elemental Mg) |
| Frequency | Once daily (evening) | Once or split daily |
| Route | Oral capsule | Oral (capsule or powder) |
Apigenin reported benefits
- Supports sleep onset
- Mild anxiolytic/relaxation
- CD38 inhibition (NAD+ preservation)
- Antioxidant and anti-inflammatory
- Potential anti-cancer research interest
Magnesium L-Threonate reported benefits
- Improved sleep quality
- Cognitive and memory support
- Stress and anxiety reduction
- Brain-penetrant magnesium
- Minimal laxative effect
- Neuroprotective potential
Related comparisons
Research and educational reference only. Not medical advice.